Liraglutide May Enable Weight Loss Amongst Obese People

Tue, 27 Oct 2009
Recent research affirms that Type 2 diabetes drug Liraglutide may enable weight loss in obese people who are not suffering from diabetes .

The study monitored the impact Liraglutide has on bodyweight in obese people who have not got Type 2 diabetes.

This research was undertaken in 19 locations across Europe; 564 people participated, aged between 18 and 65 years with a BMI of between 30 and 40.

The participants adhered to a calorie-restricted diet and upped their physical activity as the trial progressed.

The study uncovered that participants on Liraglutide experienced more weight loss than those who were taking a placebo or the weight-loss drug Orlistat.

The findings established that Liraglutide increases the choice of treatments for Type 2 diabetics as it offers improved blood glucose control as well as weight loss.

Further research is needed to confirm the above findings.

Link to this page

Copy and Paste the following HTML into your page.